Analysis of Computed Tomography Derived Maps for Determining Changes of the Liver Volume After Exposure to Radiotherapy
NCT07320755 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2026-01-09
Summary
Radiotherapy is commonly used to treat cancers involving the liver or nearby organs. While effective, radiation exposure can affect healthy liver tissue and may lead to changes in liver size and function. Monitoring these changes is important to improve treatment planning and reduce the risk of liver-related complications.
This study aims to evaluate changes in liver volume using computed tomography (CT) imaging before and after radiotherapy. By analyzing CT-derived liver maps, the study seeks to better understand how the liver responds to radiation treatment over time.
The study will include patients who undergo radiotherapy and have CT imaging performed as part of their routine clinical care. No additional procedures or treatments will be required for participation. The findings of this study may help improve future radiotherapy planning and patient monitoring by providing better information on liver volume changes following radiation exposure.
Conditions
- Intra-abdominal Malignancies
- Liver as Organ at Risk
- Radiation-related Liver Changes
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Amr Farouk Mourad, Prof. · Assiut University
-
Omar Mostafa Mahmoud Mohammad, Assist Prof. · Assiut University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-01
- Primary Completion
- 2026-01-01
- Completion
- 2027-12-31
More Related Trials
-
Prediction Model Based on Computed Tomography Liver Volume for the Short-term Mortality in Hepatitis B Related Acute-on-Chronic
NCT03977857 ·Status: COMPLETED
-
Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
NCT06060769 ·Status: RECRUITING
-
Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)
NCT01234701 ·Status: COMPLETED
-
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
NCT03880721 ·Status: UNKNOWN
-
Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique
NCT00172705 ·Status: UNKNOWN
-
Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .
NCT06168357 ·Status: NOT_YET_RECRUITING
-
Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases
NCT01631318 ·Status: COMPLETED ·Phase: NA
-
The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions
NCT07055048 ·Status: NOT_YET_RECRUITING
-
Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver Fibrosis
NCT05008263 ·Status: COMPLETED
-
Follow up After TACE by Elastography and Color Doppler.
NCT06070623 ·Status: NOT_YET_RECRUITING
-
Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
NCT07059936 ·Status: RECRUITING
-
Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas
NCT04813432 ·Status: UNKNOWN
-
Assessment of Fatty Liver With Thermo-acoustic Device
NCT04302051 ·Status: WITHDRAWN
-
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy
NCT01281683 ·Status: UNKNOWN
-
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
NCT03731910 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma
NCT01490203 ·Status: COMPLETED
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function
NCT03766555 ·Status: UNKNOWN ·Phase: NA
-
Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB
NCT06616103 ·Status: NOT_YET_RECRUITING
-
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
NCT01163526 ·Status: TERMINATED
-
Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data
NCT06317181 ·Status: RECRUITING ·Phase: NA
-
3T MRI to Predict TACE Response of HCC
NCT02070822 ·Status: UNKNOWN
-
Comparison Between LDCT With DL Recontruction and Standard Dose CT
NCT05324046 ·Status: UNKNOWN
-
Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery
NCT01738217 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Model Based on Computed Tomography Imaging Parameters to Predict Poor Survival in Patients With Liver Cirrhosis
NCT05208736 ·Status: UNKNOWN